Skip to main content
. 2022 Jan 4;23(1):524. doi: 10.3390/ijms23010524

Figure 4.

Figure 4

Results of testing the antimicrobial effects of peptides R23F, R23DI, R23EI against MRSA (Gram-positive, G+), S. aureus (Gram-positive, G+), P. aeruginosa (Gram-negative, G−), E. coli (Gram-negative, G−), and B. cereus (Gram-positive, G+). Bacteria were grown on solid agar medium LB. Application scheme: 1—peptide 300 μM; 2—peptide 150 μM; 3—peptide 75 μM; 4—peptide 37.5 μM; 5—peptide 18.75 μM; 6—LB with DMSO 2% (v/v); 7—gentamicin sulfate 1700 μM.